PARP1 and cystic fibrosis: Similarly, reducing PARP-1 activity by 85% in ileum from transgenic CF mice (Cftrtm1Eur) partially rescued ΔF508 CFTR activity to 7% of wild type mouse levels, and similar correction (7.8%) was observed in vivo by measuring salivary secretion.